Announcements Trials

Browse Landscape

Status

Completed 5 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 12 Neuroendocrine Tumors 5 Neoplasm Metastasis 5 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Adenoma, Islet Cell 3 Recurrence 2 Meningioma 2 Glioblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Carcinoid Tumor 2 von Hippel-Lindau Disease 1 Unilateral Breast Neoplasms 1 Tuberous Sclerosis 1 Thymus Neoplasms 1 Sarcoma 1 Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Lymphangioleiomyomatosis 1 Locally Advanced Thyroid Gland Carcinoma 1 Kidney Neoplasms 1 HR+/HER2- Advanced Breast Cancer 1 Glioma 1 Gastroenteropancreatic Neuroendocrine Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gallbladder Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Brain Neoplasms 1

Interventions

Sirolimus 1 Respiratory Function Tests 1 Phlebotomy 1 Imatinib Mesylate 1 Genetic Testing 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphangioleiomyomatosis × Everolimus × Clear all

NCT02432560 2024-12-24

MIDAS

University of Cincinnati

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡